避孕藥具市場規模、佔有率及成長分析（按產品、通路及地區分類）－2026-2033年產業預測

預計到 2024 年，避孕藥具市場規模將達到 325.5 億美元，到 2025 年將成長至 349.6 億美元，到 2033 年將成長至 618.9 億美元，預測期（2026-2033 年）的複合年成長率為 7.4%。

受多種因素驅動，全球避孕市場正經歷顯著擴張。人們對計劃生育意識的提高以及性行為感染（STI）發生率的上升是推動這一成長的核心動力。此外，技術進步（包括長效可逆避孕方法（LARCs））和選擇的增加也促進了對有效避孕措施的需求。政府為促進計劃生育和生殖健康所採取的措施進一步鞏固了這一有利局面。然而，該市場也面臨許多挑戰，例如社會偏見、文化障礙以及部分地區避孕服務取得受限等。儘管存在這些障礙，但人們對女性健康的日益關注以及對避孕作為一種賦權手段的接受度不斷提高，預計將顯著推動該市場的未來發展。

避孕藥市場成長要素

推動避孕藥具市場成長的主要因素是人們對計劃生育和生殖健康的認知和接受度不斷提高。隨著人們對避孕在控制人口成長和促進女性健康方面的益處了解的加深，避孕方法的需求激增。政府推行的計劃生育計劃和項目進一步強化了這一趨勢。此外，眾多組織在提高大眾對不同避孕方式的認知方面發揮著至關重要的作用，從而促進了社會對相關知識的了解。這些共同努力正在推動市場需求的成長，並擴大人們獲得生殖健康解決方案的途徑。

避孕藥市場限制

全球避孕器市場面臨許多限制因素，主要包括文化和宗教障礙，這些障礙阻礙了不同地區對避孕方法的接受和使用。在某些社區，傳統信仰和宗教教義抑製或限制了避孕器的使用，導致其普及率較低。另一個挑戰是避孕選擇管道匱乏，尤其是在農村和醫療服務不足的地區。供應有限、高成本以及分銷網路不完善等因素會阻礙避孕藥具的有效使用，尤其是在開發中國家。消除這些文化和後勤障礙對於擴大可靠避孕方法的覆蓋範圍和促進市場成長至關重要。

避孕器市場趨勢

全球避孕器市場的一個顯著趨勢是，人們對長效可逆避孕方法（LARCs）的興趣日益濃厚，例如子宮內避孕器（IUD）和皮下植入。由於其高效性和低維護成本，這些方法越來越受到尋求可靠便捷避孕方案的女性的青睞。科技進步也推動了LARCs的普及，帶來了更多創新且人性化的設計，進一步提升了其吸引力。這一成長趨勢凸顯了人們對有效且永續避孕方法的普遍需求，也反映了全球對計劃生育和生殖健康觀念的轉變。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 案例研究
• 客戶和購買標準分析
• 貿易分析
• 原料分析

全球避孕藥具市場規模（依產品分類）及複合年成長率（2026-2033 年）

• 避孕藥
  • 避孕藥
  • 修補
  • 注射
• 避孕裝置
  • 保險套
  • 男用保險套
  • 女性用保險套
  • 皮下植入式避孕器
  • 子宮內避孕器（IUD）
  • 含銅子宮內避孕器（IUD）
  • 含激素子宮內避孕器（IUD）
  • 陰道環
  • 陰道內避孕環

全球避孕藥具市場規模（依通路分類）及複合年成長率（2026-2033 年）

• 醫療機構
• 藥局
• 其他

全球避孕藥具市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Bayer AG
• Pfizer Inc.
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Organon & Co.
• Agile Therapeutics
• Mayer Laboratories, Inc.
• CooperSurgical, Inc.
• Afaxys, Inc.
• Mylan NV（Viatris）
• DKT International
• Medisafe Distribution Inc.
• Veru Inc.
• Cipla Ltd.
• Lupin Pharmaceuticals
• Mithra Pharmaceuticals
• Pregna International Limited
• Fuji Latex Co., Ltd.
• Karex Berhad
• Cupid Limited

結論與建議

Contraceptives Market size was valued at USD 32.55 Billion in 2024 and is poised to grow from USD 34.96 Billion in 2025 to USD 61.89 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global contraceptives market is experiencing notable expansion due to various driving factors. Growing awareness around family planning and a heightened incidence of sexually transmitted infections (STIs) are central to this growth. Additionally, the demand for effective contraceptive methods is on the rise, supported by advancements in technology, including long-acting reversible contraceptives (LARCs) and an expanding array of options. Government initiatives advocating for family planning and reproductive health further enhance this positive landscape. However, the market faces challenges, including social stigma, cultural barriers, and restricted access in some regions. Despite these obstacles, the increasing focus on women's health and the broadening acceptance of contraception as a means of empowerment are poised to significantly bolster the market's future development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segments Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for growth in the contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As people gain more knowledge about the benefits of contraception for managing population growth and enhancing women's health, the demand for contraceptive methods has surged. This trend is further bolstered by government initiatives and programs designed to advocate for family planning. Additionally, various organizations play a significant role in raising awareness about different contraceptive options, thereby fostering a more informed public. This collective effort is driving an increase in market demand and expanding access to reproductive health solutions.

Restraints in the Contraceptives Market

The global contraceptives market faces significant restraints primarily due to cultural and religious barriers that hinder the acceptance and utilization of contraceptive methods in various regions. In certain communities, traditional beliefs and religious doctrines discourage or limit the use of contraceptives, resulting in lower adoption rates among the population. Additionally, inadequate access to contraceptive options, particularly in rural and underserved areas, poses a challenge. Factors such as limited availability, high costs, and insufficient distribution networks can obstruct the effective use of contraceptives, particularly in developing nations. Addressing these cultural and logistical hurdles is essential for promoting greater accessibility to reliable contraception and fostering the market's growth.

Market Trends of the Contraceptives Market

A prominent trend in the global contraceptives market is the surging interest in long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are increasingly favored by women due to their high efficacy and low maintenance requirements, thereby addressing the need for reliable and convenient birth control solutions. The shift towards LARCs is also driven by technology advancements that have introduced more innovative and user-friendly designs, enhancing their appeal. This growing trend underscores a broader movement towards effective, sustainable contraceptive methods, reflecting changing attitudes towards family planning and reproductive health globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2026-2033)

• Market Overview
• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables
• Contraceptive Devices
  • Condom
  • Male Condom
  • Female Condom
  • Subdermal Implants
  • Intrauterine Devices (IUDS)
  • Copper IUDS
  • Hormonal IUDS
  • Vaginal Ring
  • Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Healthcare Facilities
• Pharmacies
• Others

Global Contraceptives Market Size & CAGR (2026-2033)

• North America (Product, Distribution Channel)
  • USA
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karex Berhad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations